Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial

Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial

Abstract Background One-year dual antiplatelet therapy (DAPT), generally aspirin in combination with a P2Y12 receptor inhibitor, has been a standard treatment for patients undergoing percutaneous coronary intervention (PCI). Prolonged DAPT has proven itself effective in further reducing cardiovascul...

Full description

Bibliographic Details
Main Authors: Jingen Li, Jianqing Ju, Zhuo Chen, Jing Liu, Fang Lu, Rui Gao, Hao Xu
Format: Article
Language:English
Published: BMC 2018-02-01
Series:Trials
Subjects:
Coronary artery disease
Antiplatelet therapy
Guanxinning tablet
Chinese herbal medicine
Cluster randomized trial
Online Access:http://link.springer.com/article/10.1186/s13063-017-2373-x

Internet

http://link.springer.com/article/10.1186/s13063-017-2373-x

Similar Items